Interstitial lung disease induced by apalutamide therapy for castration‐resistant prostate cancer: A report of a rare case-Reference-Cited by-同舟云学术

Interstitial lung disease induced by apalutamide therapy for castration‐resistant prostate cancer: A report of a rare case

Published:2022-03-03 Issue:3 Volume:5 Page:153-155
ISSN:2577-171X
Container-title:IJU Case Reports
language:en
Short-container-title:IJU Case Reports

Author:

Kirishima Fumiaki¹^ORCID,Shigematsu Yoshinori¹,Kobayashi Kanao¹^ORCID

Affiliation:

1. Department of Urology Chugoku Rosai Hospital Kure City Hiroshima Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iju5.12420

Reference12 articles.

1. INTERSTITIAL PNEUMONITIS FOLLOWING BICALUTAMIDE TREATMENT FOR PROSTATE CANCER

2. Interstitial pneumonitis induced by bicalutamide and leuprorelin acetate for prostate cancer

3. Successful recovery from interstitial pneumonitis, induced by bicalutamide and leuprorelin acetate given as treatment for prostate cancer;Shioi K;Hinyokika Kiyo,2005

4. Interstitial pneumonitis induced by bicalutamide and goserelin acetate given for prostate cancer;Kobayashi K;Nishinihon J. Urol.,2006

5. Interstitial pneumonitis induced by bicalutamide given for prostate cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interstitial Lung Disease Caused by Apalutamide for Metastatic Castration-Sensitive Prostate Cancer;Archivos de Bronconeumología;2024-08

2. Apalutamida y enfermedad intersticial pulmonar, una asociación a tener en cuenta;Revista Española de Casos Clínicos en Medicina Interna;2024-04-24

3. Editorial Comment to Interstitial lung disease induced by apalutamide therapy for castration‐resistant prostate cancer: A report of a rare case;IJU Case Reports;2022-03-08